These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19661193)

  • 1. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.
    Marioni RE; Stewart MC; Murray GD; Deary IJ; Fowkes FG; Lowe GD; Rumley A; Price JF
    Psychosom Med; 2009 Oct; 71(8):901-6. PubMed ID: 19661193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study.
    Marioni RE; Deary IJ; Strachan MW; Lowe GD; Rumley A; Murray GD; Price JF
    Age Ageing; 2010 May; 39(3):354-9. PubMed ID: 20197283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.
    Rafnsson SB; Deary IJ; Smith FB; Whiteman MC; Rumley A; Lowe GD; Fowkes FG
    J Am Geriatr Soc; 2007 May; 55(5):700-7. PubMed ID: 17493189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Marioni RE; Strachan MW; Reynolds RM; Lowe GD; Mitchell RJ; Fowkes FG; Frier BM; Lee AJ; Butcher I; Rumley A; Murray GD; Deary IJ; Price JF
    Diabetes; 2010 Mar; 59(3):710-3. PubMed ID: 19959761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.
    Mangiafico RA; Sarnataro F; Mangiafico M; Fiore CE
    Age Ageing; 2006 Jan; 35(1):60-5. PubMed ID: 16364935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemorheological predictors of cognitive decline: the Edinburgh Artery Study.
    Rafnsson S; Deary IJ; Whiteman MC; Rumley A; Lowe GD; Fowkes FG
    Age Ageing; 2010 Mar; 39(2):217-22. PubMed ID: 20097662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.
    Reynolds RM; Strachan MW; Labad J; Lee AJ; Frier BM; Fowkes FG; Mitchell R; Seckl JR; Deary IJ; Walker BR; Price JF;
    Diabetes Care; 2010 Apr; 33(4):714-20. PubMed ID: 20097784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study.
    Sluiman AJ; McLachlan S; Forster RB; Strachan MWJ; Deary IJ; Price JF
    Diabetologia; 2022 Mar; 65(3):467-476. PubMed ID: 34932135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-specific associations of inflammation markers with cognitive decline.
    West NA; Kullo IJ; Morris MC; Mosley TH
    Exp Gerontol; 2020 Sep; 138():110986. PubMed ID: 32497552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inflammatory proteins and cognitive decline in older persons.
    Dik MG; Jonker C; Hack CE; Smit JH; Comijs HC; Eikelenboom P
    Neurology; 2005 Apr; 64(8):1371-7. PubMed ID: 15851726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample.
    Luciano M; Marioni RE; Gow AJ; Starr JM; Deary IJ
    Psychosom Med; 2009 May; 71(4):404-9. PubMed ID: 19398500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is related to future cognitive impairment and decline in elderly individuals with cardiovascular disease.
    Weinstein G; Lutski M; Goldbourt U; Tanne D
    Arch Gerontol Geriatr; 2017; 69():31-37. PubMed ID: 27886564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.
    Cohen-Manheim I; Doniger GM; Sinnreich R; Simon ES; Pinchas-Mizrachi R; Otvos JD; Kark JD
    PLoS One; 2015; 10(9):e0138036. PubMed ID: 26406330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study.
    Matsushima J; Kawashima T; Nabeta H; Imamura Y; Watanabe I; Mizoguchi Y; Kojima N; Yamada S; Monji A
    J Affect Disord; 2015 Mar; 173():9-14. PubMed ID: 25462389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoring system to predict early carotid restenosis after eversion endarterectomy by analysis of inflammatory markers.
    Tanaskovic S; Radak D; Aleksic N; Calija B; Maravic-Stojkovic V; Nenezic D; Ilijevski N; Popov P; Vucurevic G; Babic S; Matic P; Gajin P; Vasic D; Rancic Z
    J Vasc Surg; 2018 Jul; 68(1):118-127. PubMed ID: 29503001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
    Welsh P; Woodward M; Rumley A; Lowe G
    Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic markers of inflammation and cognitive decline in old age.
    Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
    J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
    Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
    Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine and cognitive decline in older hypertensive subjects.
    Narayan SK; Saxby BK; Firbank MJ; O'Brien JT; Harrington F; McKeith IG; Hansrani M; Stansby G; Ford GA
    Int Psychogeriatr; 2011 Dec; 23(10):1607-15. PubMed ID: 21554791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial.
    Price JF; Stewart MC; Deary IJ; Murray GD; Sandercock P; Butcher I; Fowkes FG;
    BMJ; 2008 Sep; 337():a1198. PubMed ID: 18762476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.